-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-1 Addressing Relapsed Disease Following Hematopoietic Stem Cell Transplantation

Program: Scientific Program
Session: Challenges in Cell Therapy: Relapse and Toxicities
Saturday, December 5, 2020, 9:25 AM-9:30 AM

John F. DiPersio, MD

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO

Disclosures: DiPersio: Magenta Therapeutics: Membership on an entity's Board of Directors or advisory committees.

Previous Presentation | Next Presentation >>